UroGen Pharma Analyst Ratings
Ladenburg Thalmann Maintains Buy on UroGen Pharma, Raises Price Target to $53.5
Ladenburg Thalmann Raises Price Target on UroGen Pharma to $53.50 From $48, Maintains Buy Rating
UroGen Pharma Analyst Ratings
UroGen Pharma Analyst Ratings
UroGen Pharma Analyst Ratings
UroGen Pharma Analyst Ratings
UroGen Pharma Analyst Ratings
UroGen Pharma Analyst Ratings
UroGen Pharma Analyst Ratings
Oppenheimer Adjusts UroGen Pharma Price Target to $35 From $32, Maintains Outperform Rating
UroGen Pharma Analyst Ratings
Oppenheimer Adjusts UroGen Pharma Price Target to $32 From $33, Maintains Outperform Rating
HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $54 Price Target
UroGen Pharma Analyst Ratings
UroGen Pharma Analyst Ratings
Urogen Pharma (URGN) Gets a Buy From H.C. Wainwright
HC Wainwright & Co. Maintains Buy on UroGen Pharma, Raises Price Target to $54
UroGen Pharma Analyst Ratings
UroGen Pharma Analyst Ratings
No Data